Opportunity ID: 332135

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-128
Funding Opportunity Title: The NCI Transition Career Development Award (K22 – Independent Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.398 — Cancer Research Manpower
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 15, 2021
Last Updated Date: Mar 15, 2021
Original Closing Date for Applications: Mar 14, 2024
Current Closing Date for Applications: Mar 14, 2024
Archive Date: Apr 19, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Public housing authorities/Indian housing authorities
Special district governments
For profit organizations other than small businesses
County governments
City or township governments
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Private institutions of higher education
Public and State controlled institutions of higher education
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position. This FOA is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants proposing a clinical trial, a clinical trial feasibility study, or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOAs (PAR-21-XXX or PAR-21-YYY) .
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-128.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 332135 Full Announcement-PAR-21-128 -> PAR-21-128-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00265953 May 12, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00270104 Nov 15, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278028 Nov 07, 2022 Mar 14, 2024 View

Package 1

Mandatory forms

332135 RR_SF424_2_0-2.0.pdf

332135 PHS398_CoverPageSupplement_5_0-5.0.pdf

332135 RR_OtherProjectInfo_1_4-1.4.pdf

332135 PerformanceSite_2_0-2.0.pdf

332135 RR_KeyPersonExpanded_2_0-2.0.pdf

332135 RR_Budget_1_4-1.4.pdf

332135 PHS398_CareerDevelopmentAwardSup_5_0-5.0.pdf

332135 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

332135 RR_SubawardBudget30_1_4-1.4.pdf

332135 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

332135 RR_SF424_5_0-5.0.pdf

332135 PHS398_CoverPageSupplement_5_0-5.0.pdf

332135 RR_OtherProjectInfo_1_4-1.4.pdf

332135 PerformanceSite_4_0-4.0.pdf

332135 RR_KeyPersonExpanded_4_0-4.0.pdf

332135 RR_Budget_3_0-3.0.pdf

332135 PHS398_CareerDevelopmentAwardSup_5_0-5.0.pdf

332135 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

332135 RR_SubawardBudget30_3_0-3.0.pdf

332135 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

332135 RR_SF424_5_0-5.0.pdf

332135 PHS398_CoverPageSupplement_5_0-5.0.pdf

332135 RR_OtherProjectInfo_1_4-1.4.pdf

332135 PerformanceSite_4_0-4.0.pdf

332135 RR_KeyPersonExpanded_4_0-4.0.pdf

332135 RR_Budget_3_0-3.0.pdf

332135 PHS398_CareerDevelopmentAwardSup_6_0-6.0.pdf

332135 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

332135 RR_SubawardBudget30_3_0-3.0.pdf

332135 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T19:57:21-05:00

Share This Post, Choose Your Platform!

About the Author: